Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation

British Journal of Surgery

Volumn 98, Issue 2, 2011, Pages 261-267

  Shirabe, K ^a   Aishima, S ^a   Taketomi, A ^a   Soejima, Y ^a   Uchiyama, H ^a   Kayashima, H ^a   Ninomiya, M ^a   Mano, Y ^a   Maehara, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; LIVING DONOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650601141     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7311     Document Type: Article

References (24)

1. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K,. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analysis. Hepatology 1991; 14: 802-805.
2. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al., Liver transplantation for the treatment of small hepatocellular carcinoma. N Engl J Med 1996; 334: 693-639.
3. Raia S, Nery JR, Miles S,. Liver transplantation from live donors. Lancet 1989; 2: 497.
4. Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, et al., Successful living-related partial liver transplantation to an adult patient. Lancet 1994; 343: 1233-1234.
5. Shimada M, Yonemura Y, Ijichi H, Harada N, Shiotani S, Ninomiya M, et al., Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value. Transplant Proc 2005; 37: 1177-1179.
6. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, et al., Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007; 83: 893-899.
7. Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, et al., Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009; 87: 531-537.
8. Sugawara Y, Tamura S, Makuuchi M,. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007; 25: 310-312.
9. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al., Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
10. Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M, et al., Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987; 60: 810-819.
11. Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H,. Hepatic resection for hepatocellular carcinoma. Am J Surg 1997; 173: 288-291.
12. Hui AM, Takayama T, Sano T, Kubota K, Akahane M, Ohtomo K, et al., Predictive value of gross classification of hepatocellular carcinoma. J Hepatol 2000; 33: 975-979.
13. Shimada M, Rikimaru T, Hamatsu T, Yamashita Y, Terashi T, Taguchi K, et al., The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg 2001; 182: 177-182.
14. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al., Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207.
15. Inayoshi J, Ichida T, Sugitani S, Tsuboi Y, Genda T, Honma N, et al., Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment. J Gastroenterol Hepatol 2003; 18: 673-677.
16. Kondo K, Chijiwa K, Makino I, Kai M, Maehara N, Ohuchida J, et al., Risk factor for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2005; 12: 399-404.
17. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, et al., Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375-1382.
18. Choi GH, Han DH, Kim DH, Choi SB, Kang CM, Kim KS, et al., Outcome after curative resection for a huge (> or = 10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg 2009; 198: 693-701.
19. United Network for Organ Sharing. Policy 3.6. [accessed 1 August 2010].
20. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211: 277-287.
21. Gibson JB, Sobin LH,. Histological Typing of Tumours of the Liver, Biliary Tract and Pancreas. International Classification of Tumours. No. 20. World Health Organization: Geneva, 1978.
22. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M,. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003; 26: 142-147.
23. Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y,. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990; 66: 2174-2179.
24. Matsuura S, Aishima S, Taguchi K, Asayama Y, Terashi T, Honda H, et al., 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1. Histopathology 2005; 47: 382-390.